RateCaptain
  • Home
    • About Us
    • Contact Us
  • FX Rates
  • Money Market
  • Cryptocurrency
  • Commodities
  • Corporates
No Result
View All Result
Subscribe
  • Home
    • About Us
    • Contact Us
  • FX Rates
  • Money Market
  • Cryptocurrency
  • Commodities
  • Corporates
No Result
View All Result
RateCaptain
No Result
View All Result
Home

$189m clinical trial delays local COVID-19 vaccine production

Rate Captain by Rate Captain
May 20, 2021
in Health
Reading Time: 1 min read
A A
0
Share on FacebookShare on TwitterShare on WhatsappShare on Telegram

Lack of funds is stalling efforts being made by the African Centre of Excellence for Genomics of Infectious Diseases, Ede, Osun State, to develop a locally made COVID-19 vaccine.

The centre’s Director, Christian Hapi, confirmed this to journalists in a telephone interview on Wednesday.

AlsoRead

Ghana Set to Start Production of Coronavirus Vaccines in January 2024

UNITAID Announces the Discovery of the Long –lasting HIV Injection

Japanese Government Donates Over 850,000 Coronavirus Vaccines to Nigeria

Hapi, who said the process had started, added that the centre could not proceed to the stage of clinical trials because of a lack of funds.

“There are activities for development (of local COVID-19 vaccine). We are at the stage for clinical trials.

“We have not done the clinical trials because we are looking for funds to proceed,” he said.

When asked how much is the will the centre require to proceed to the clinical trial stage, Hapi said, “The amount required for the clinical trial is $189m.”

When further asked if the centre had approached the Federal Government and what the response was, he said, “Yes, we approached the Federal Government and we are still waiting for a response.”

Previous Post

FG approves Lagos, Abuja, 2 other international airports as Special Economic Zones

Next Post

Access Bank completes acquisition of Mozambique’s African Banking Corporation

Related News

Ghana Set to Start Production of Coronavirus Vaccines in January 2024

by Rate Captain
March 30, 2022
0

Ghana, an African country will to start the production of coronavirus vaccines in January 2024. This is intended to provide...

UNITAID Announces the Discovery of the Long –lasting HIV Injection

by Rate Captain
March 21, 2022
0

UNITAID announced a groundbreaking development by the ViiV healthcare on the discovery of the first injection to offer long-lasting protection...

Japanese Government Donates Over 850,000 Coronavirus Vaccines to Nigeria

by Rate Captain
March 4, 2022
0

The Federal Government of Nigeria has received about 859,000 doses of AstraZeneca COVID-19 vaccines and 175 solar direct drive refrigerators...

Another Covid-19 Variant “DELTACRON” Detected in Cyprus

by Rate Captain
January 12, 2022
0

Another Covid-19 variant “Deltacron” has been detected in Cyprus. The deltacron variant is a combination strain of Covid-19 that fuses...

Next Post

Access Bank completes acquisition of Mozambique’s African Banking Corporation

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Recommended

Showmax’s Costly Gamble: Platform loses $2.50 for Every $1 Earned in Revenue

Showmax’s Costly Gamble: Platform loses $2.50 for Every $1 Earned in Revenue

March 10, 2026
FCMB Group Plc Reports Remarkable 108% Year-on-Year Profit Growth in 9M 2023

FCMB Group Completes N500bn Recapitalisation, Secures International Banking Licence

March 10, 2026

Popular Story

  • FCMB Group Plc Reports Remarkable 108% Year-on-Year Profit Growth in 9M 2023

    FCMB Group Completes N500bn Recapitalisation, Secures International Banking Licence

    0 shares
    Share 0 Tweet 0
  • NNPC Logs N385bn Profit in January as Oil Output Climbs to 1.64mbpd

    0 shares
    Share 0 Tweet 0
  • Showmax’s Costly Gamble: Platform loses $2.50 for Every $1 Earned in Revenue

    0 shares
    Share 0 Tweet 0
  • NGX All-Share Index Breaks Historic 197,000 Barrier in Landmark Session

    0 shares
    Share 0 Tweet 0
  • ‘How Naira Depreciation Hurts Aviation Industry’

    0 shares
    Share 0 Tweet 0

RateCaptain

We bring you the most accurate in new and market data. Check our landing page for details.

  • Home
  • About Us
  • Privacy Policy
  • Terms & Conditions
  • Disclaimer
  • Cookie Policy
  • Contact Us

Copyright © 2022 RateCaptain - All rights reserved by RateCaptain.

No Result
View All Result
  • Home
    • About Us
    • Contact Us
  • FX Rates
  • Money Market
  • Cryptocurrency
  • Commodities
  • Corporates

Copyright © 2022 RateCaptain - All rights reserved by RateCaptain.

RateCaptain
Manage Cookie Consent
To provide the best experiences, we use technologies like cookies to store and/or access device information. Consenting to these technologies will allow us to process data such as browsing behavior or unique IDs on this site. Not consenting or withdrawing consent, may adversely affect certain features and functions.
Functional Always active
The technical storage or access is strictly necessary for the legitimate purpose of enabling the use of a specific service explicitly requested by the subscriber or user, or for the sole purpose of carrying out the transmission of a communication over an electronic communications network.
Preferences
The technical storage or access is necessary for the legitimate purpose of storing preferences that are not requested by the subscriber or user.
Statistics
The technical storage or access that is used exclusively for statistical purposes. The technical storage or access that is used exclusively for anonymous statistical purposes. Without a subpoena, voluntary compliance on the part of your Internet Service Provider, or additional records from a third party, information stored or retrieved for this purpose alone cannot usually be used to identify you.
Marketing
The technical storage or access is required to create user profiles to send advertising, or to track the user on a website or across several websites for similar marketing purposes.
  • Manage options
  • Manage services
  • Manage {vendor_count} vendors
  • Read more about these purposes
View preferences
  • {title}
  • {title}
  • {title}
?>